FDA.reportPublic FDA data

Cryptococcus neoformans antigen IVD, kit, enzyme immunoassay (EIA)

Definition
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of antigens from the yeast Cryptococcus neoformans in a clinical specimen, using an enzyme immunoassay (EIA) method.
GUDID devices
2
Last updated
2020-04-28 02:03:30

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
00840733101229PREMIER Cryptococcal AntigenMERIDIAN BIOSCIENCE, INC.6020962016-09-23
00816387020759IMMYImmuno-Mycologics, Inc.CRY1012016-09-24